AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...

BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and ...

Pfizer reported at #ESMO that an experimental antibody helped cancer patients with a condition known as cachexia.

One of the big presentations of this year’s ESMO (at least in our view) comes tomorrow morning bright and early. David Spigel ...

Mystery H5 flu case had a close contact who was ill at same time; CDC hopes blood tests will show if there was a connection.

A new therapy approved by the FDA is one of the first major brain tumor breakthroughs in decades, say neuro-oncologists.

A targeted immunotherapy being developed by iTeos Therapeutics and GSK, it was reported at #ESMO, delivered promising ...

A growing number of people with type 1 diabetes are becoming overweight or obese, in part because insulin can cause weight ...

Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

For years, health insurers battled to gain market share in the lucrative privatized Medicare program. Now, the opposite is ...